vs
PUMA BIOTECHNOLOGY, INC.（PBYI）与Perimeter Solutions, Inc.（PRM）财务数据对比。点击上方公司名可切换其他公司
Perimeter Solutions, Inc.的季度营收约是PUMA BIOTECHNOLOGY, INC.的1.4倍（$102.8M vs $75.5M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs 19.2%），PUMA BIOTECHNOLOGY, INC.自由现金流更多（$14.4M vs $11.6M），过去两年Perimeter Solutions, Inc.的营收复合增速更高（31.9% vs 31.3%）
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
Perimeter Solutions是一家以色列云与网络安全企业，专为各类机构打造基于零信任架构的安全远程网络方案，其技术可替代VPN、防火墙等传统安全硬件设备，助力企业简化网络安全部署，提升远程访问的安全性与效率。
PBYI vs PRM — 直观对比
营收规模更大
PRM
是对方的1.4倍
$75.5M
营收增速更快
PBYI
高出8.6%
19.2%
自由现金流更多
PBYI
多$2.8M
$11.6M
两年增速更快
PRM
近两年复合增速
31.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $75.5M | $102.8M |
| 净利润 | — | $-140.2M |
| 毛利率 | 69.3% | 45.2% |
| 营业利润率 | 22.7% | -160.7% |
| 净利率 | — | -136.5% |
| 营收同比 | 27.7% | 19.2% |
| 净利润同比 | — | -197.3% |
| 每股收益（稀释后） | $0.26 | $-0.89 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PBYIPRM
| Q4 25 | $75.5M | $102.8M | ||
| Q3 25 | $54.5M | $315.4M | ||
| Q2 25 | $52.4M | $162.6M | ||
| Q1 25 | $46.0M | $72.0M | ||
| Q4 24 | $59.1M | $86.2M | ||
| Q3 24 | $80.5M | $288.4M | ||
| Q2 24 | $47.1M | $127.3M | ||
| Q1 24 | $43.8M | $59.0M |
净利润PBYIPRM
| Q4 25 | — | $-140.2M | ||
| Q3 25 | $8.8M | $-90.7M | ||
| Q2 25 | $5.9M | $-32.2M | ||
| Q1 25 | $3.0M | $56.7M | ||
| Q4 24 | — | $144.2M | ||
| Q3 24 | $20.3M | $-89.2M | ||
| Q2 24 | $-4.5M | $21.6M | ||
| Q1 24 | $-4.8M | $-82.6M |
毛利率PBYIPRM
| Q4 25 | 69.3% | 45.2% | ||
| Q3 25 | 77.7% | 63.1% | ||
| Q2 25 | 76.5% | 62.4% | ||
| Q1 25 | 77.1% | 39.1% | ||
| Q4 24 | 76.4% | 48.6% | ||
| Q3 24 | 63.9% | 62.8% | ||
| Q2 24 | 77.4% | 57.6% | ||
| Q1 24 | 75.5% | 35.1% |
营业利润率PBYIPRM
| Q4 25 | 22.7% | -160.7% | ||
| Q3 25 | 17.6% | -27.7% | ||
| Q2 25 | 12.7% | -16.1% | ||
| Q1 25 | 8.7% | — | ||
| Q4 24 | 22.6% | 71.1% | ||
| Q3 24 | 27.4% | -12.2% | ||
| Q2 24 | -4.6% | 35.4% | ||
| Q1 24 | -5.3% | -126.8% |
净利率PBYIPRM
| Q4 25 | — | -136.5% | ||
| Q3 25 | 16.2% | -28.7% | ||
| Q2 25 | 11.2% | -19.8% | ||
| Q1 25 | 6.5% | 78.7% | ||
| Q4 24 | — | 167.2% | ||
| Q3 24 | 25.2% | -30.9% | ||
| Q2 24 | -9.6% | 17.0% | ||
| Q1 24 | -11.0% | -139.8% |
每股收益（稀释后）PBYIPRM
| Q4 25 | $0.26 | $-0.89 | ||
| Q3 25 | $0.17 | $-0.62 | ||
| Q2 25 | $0.12 | $-0.22 | ||
| Q1 25 | $0.06 | $0.36 | ||
| Q4 24 | $0.40 | $1.00 | ||
| Q3 24 | $0.41 | $-0.61 | ||
| Q2 24 | $-0.09 | $0.14 | ||
| Q1 24 | $-0.10 | $-0.57 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $97.5M | $325.9M |
| 总债务越低越好 | $22.7M | $669.1M |
| 股东权益账面价值 | $130.3M | $1.1B |
| 总资产 | $216.3M | $2.7B |
| 负债/权益比越低杠杆越低 | 0.17× | 0.59× |
8季度趋势，按日历期对齐
现金及短期投资PBYIPRM
| Q4 25 | $97.5M | $325.9M | ||
| Q3 25 | $94.4M | $340.6M | ||
| Q2 25 | $96.0M | $140.7M | ||
| Q1 25 | $93.2M | $200.1M | ||
| Q4 24 | $101.0M | $198.5M | ||
| Q3 24 | $96.7M | $223.1M | ||
| Q2 24 | $96.8M | $43.2M | ||
| Q1 24 | $107.2M | $38.7M |
总债务PBYIPRM
| Q4 25 | $22.7M | $669.1M | ||
| Q3 25 | $34.0M | $668.8M | ||
| Q2 25 | $45.3M | $668.4M | ||
| Q1 25 | $56.7M | $668.1M | ||
| Q4 24 | $68.0M | $667.8M | ||
| Q3 24 | $79.3M | $667.4M | ||
| Q2 24 | $90.7M | $667.1M | ||
| Q1 24 | $102.0M | $666.8M |
股东权益PBYIPRM
| Q4 25 | $130.3M | $1.1B | ||
| Q3 25 | $115.3M | $1.1B | ||
| Q2 25 | $104.7M | $1.2B | ||
| Q1 25 | $97.1M | $1.2B | ||
| Q4 24 | $92.1M | $1.2B | ||
| Q3 24 | $71.1M | $1.0B | ||
| Q2 24 | $48.5M | $1.1B | ||
| Q1 24 | $51.0M | $1.1B |
总资产PBYIPRM
| Q4 25 | $216.3M | $2.7B | ||
| Q3 25 | $202.9M | $2.6B | ||
| Q2 25 | $194.9M | $2.5B | ||
| Q1 25 | $196.2M | $2.4B | ||
| Q4 24 | $213.3M | $2.4B | ||
| Q3 24 | $220.7M | $2.5B | ||
| Q2 24 | $205.0M | $2.3B | ||
| Q1 24 | $214.1M | $2.3B |
负债/权益比PBYIPRM
| Q4 25 | 0.17× | 0.59× | ||
| Q3 25 | 0.30× | 0.60× | ||
| Q2 25 | 0.43× | 0.57× | ||
| Q1 25 | 0.58× | 0.55× | ||
| Q4 24 | 0.74× | 0.58× | ||
| Q3 24 | 1.12× | 0.67× | ||
| Q2 24 | 1.87× | 0.62× | ||
| Q1 24 | 2.00× | 0.63× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $14.4M | $18.6M |
| 自由现金流经营现金流 - 资本支出 | $14.4M | $11.6M |
| 自由现金流率自由现金流/营收 | 19.1% | 11.3% |
| 资本支出强度资本支出/营收 | 0.0% | 6.8% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $41.7M | $208.6M |
8季度趋势，按日历期对齐
经营现金流PBYIPRM
| Q4 25 | $14.4M | $18.6M | ||
| Q3 25 | $9.7M | $198.7M | ||
| Q2 25 | $14.1M | $-2.9M | ||
| Q1 25 | $3.6M | $23.7M | ||
| Q4 24 | $15.6M | $-6.0M | ||
| Q3 24 | $11.0M | $183.0M | ||
| Q2 24 | $1.0M | $8.6M | ||
| Q1 24 | $11.2M | $2.8M |
自由现金流PBYIPRM
| Q4 25 | $14.4M | $11.6M | ||
| Q3 25 | $9.7M | $193.6M | ||
| Q2 25 | $14.1M | $-15.6M | ||
| Q1 25 | $3.6M | $18.9M | ||
| Q4 24 | $15.6M | $-12.4M | ||
| Q3 24 | $11.0M | $179.1M | ||
| Q2 24 | $1.0M | $5.0M | ||
| Q1 24 | — | $1.2M |
自由现金流率PBYIPRM
| Q4 25 | 19.1% | 11.3% | ||
| Q3 25 | 17.7% | 61.4% | ||
| Q2 25 | 26.8% | -9.6% | ||
| Q1 25 | 7.7% | 26.3% | ||
| Q4 24 | 26.4% | -14.4% | ||
| Q3 24 | 13.7% | 62.1% | ||
| Q2 24 | 2.1% | 3.9% | ||
| Q1 24 | — | 2.1% |
资本支出强度PBYIPRM
| Q4 25 | 0.0% | 6.8% | ||
| Q3 25 | 0.0% | 1.6% | ||
| Q2 25 | 0.0% | 7.8% | ||
| Q1 25 | 0.1% | 6.7% | ||
| Q4 24 | 0.0% | 7.5% | ||
| Q3 24 | 0.0% | 1.3% | ||
| Q2 24 | 0.0% | 2.9% | ||
| Q1 24 | 0.0% | 2.6% |
现金转化率PBYIPRM
| Q4 25 | — | — | ||
| Q3 25 | 1.10× | — | ||
| Q2 25 | 2.41× | — | ||
| Q1 25 | 1.21× | 0.42× | ||
| Q4 24 | — | -0.04× | ||
| Q3 24 | 0.54× | — | ||
| Q2 24 | — | 0.40× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PBYI
暂无分部数据
PRM
| Products | $87.7M | 85% |
| Service And Other | $14.8M | 14% |
